KO Cell Pools

CSNK2A1 Knockout A549 Cell pool

CSNK2A1 knockout cell pool in A549 cells, generated using ELEM Biotech's high-throughput CRISPR/Cas9 gene editing platform. This pooled knockout population provides rapid screening capabilities for gene function studies, drug target validation, and phenotypic analysis. Validated with 100% knockout efficiency.

Product Code: LM01100101266

Technical Specifications

Gene Information

Gene Name

CSNK2A1

UniProt ID

P68400

Cell Line Information

Cell Line

A549

Cell Line Name

人非小细胞肺癌细胞

Species

KO Efficiency

100%

Validation Information

Gene Validation

N/A

Protein Validation

已有WB结果

Request a Quote
Fill in your requirements and we will contact you soon

Related Products

KO Cell Pools
VRK2 Knockout A549 Cell pool
VRK2 knockout cell pool in A549 cells, generated using ELEM Biotech's high-throughput CRISPR/Cas9 gene editing platform. This pooled knockout population provides rapid screening capabilities for gene function studies, drug target validation, and phenotypic analysis. Validated with 95% knockout efficiency, ensuring robust gene silencing.

Gene: VRK2

Cell Line: A549

LM01100028116

KO Cell Pools
MAP2K3 Knockout A549 Cell pool
MAP2K3 knockout cell pool in A549 cells, generated using ELEM Biotech's high-throughput CRISPR/Cas9 gene editing platform. This pooled knockout population provides rapid screening capabilities for gene function studies, drug target validation, and phenotypic analysis. Validated with 100% knockout efficiency.

Gene: MAP2K3

Cell Line: A549

LM01100034152

KO Cell Pools
TRIO Knockout A549 Cell pool
TRIO knockout cell pool in A549 cells, generated using ELEM Biotech's high-throughput CRISPR/Cas9 gene editing platform. This pooled knockout population provides rapid screening capabilities for gene function studies, drug target validation, and phenotypic analysis. Validated with 99% knockout efficiency, ensuring robust gene silencing.

Gene: TRIO

Cell Line: A549

LM01100038382

KO Cell Pools
MAPK9 Knockout A549 Cell pool
MAPK9 knockout cell pool in A549 cells, generated using ELEM Biotech's high-throughput CRISPR/Cas9 gene editing platform. This pooled knockout population provides rapid screening capabilities for gene function studies, drug target validation, and phenotypic analysis. Validated with 99% knockout efficiency, ensuring robust gene silencing.

Gene: MAPK9

Cell Line: A549

LM01100050748

ELEM Biotech - 粒曼生物

Professional high-throughput gene editing solutions provider, dedicated to advancing drug discovery and fundamental research innovation.

Contact

Follow Us

© 2026 ELEM Biotech. All rights reserved.